Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Subscribe To Our Newsletter & Stay Updated
